Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs

29/04/2025 36 min
Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs

Listen "Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs"

Episode Synopsis

Aragen Life Sciences’s CEO Manni Kantipudi - also former CIO of Intel Asia - speaks with Citeline’s senior editor Vibha Ravi about the changing global supply chain dynamics as the industry watches a ticking time bomb of US tariffs on pharmaceuticals. Impacts on Indian CRDMOs of the US-China trade war, budget cuts at US NIH and lower funding for biotechs are discussed. 

More episodes of the podcast Citeline Podcasts